Abstract Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by the
destruction of insulin-producing beta cells in the pancreas, leading to a lifelong dependence …

The burden of type 2 diabetes mellitus on the healthcare system requires efforts to optimally
treat and manage the diabetic patients and to prevent its complications among those who …

There has been a rapid escalation of type 2 diabetes (T2D) in developing countries, with
varied prevalence according to rural vs urban habitat and degree of urbanization. Some …

Abstract Type 1 diabetes (T1D) is an autoimmune disease that usually strikes early in life,
but can affect individuals at almost any age. It is caused by autoreactive T cells that destroy …

Background Currently about 19 million people in Africa are known to be living with diabetes,
mainly Type 2 diabetes (T2DM)(95%), estimated to grow to 47 million people by 2045 …

Type 2 diabetes mellitus (T2DM) presents a significant global health challenge, evidenced
by the International Diabetes Federation's comprehensive map of diabetes prevalence …

Diabetes is among the biggest of the 21st-century global health challenges. In the US and
other high-income countries, thanks to investments in science, dedication to implementing …

Remarkable progress has been made in some aspects of diabetes care over the last 15
years, but there have also been a rising number of challenges that differ between high and …

Type 1 diabetes mellitus (T1DM) has a wide presence in children and has a high mortality
rates. The disease, if left unmanaged, poses various challenges to the patient and …

Diabetes mellitus (DM) has been known to man since antiquity. DM is a metabolic disorder
that is characterized by hyperglycemia or elevated blood glucose levels. Insulin is produced …